БАЗА МЕДИЦИНСКИХ ЗНАНИЙ

Summary of NACI statement of May 24, 2024: Interim guidance on the use of Imvamune® in the context of a routine immunization program

National Advisory Committee on ImmunizationВакцинация2024Официальная публикация

Документальный обзор ASEM

Official National Advisory Committee on Immunization document (2024) on “Summary of NACI statement of May 24, 2024: Interim guidance on the use of Imvamune® in the context of a routine immunization program”. Valid as of May 24, 2024: Summary of the National Advisory Committee on Immunization's interim guidance on the use of Imvamune in the context of a routine immunization program.

Это краткое содержание помогает найти нужный документ. В отношении клинических рекомендаций всегда сверяйтесь с официальной версией и датой её обновления.

Официальный документ

По той же теме

Summary of NACI statement of May 2026: Statement on seasonal influenza vaccines for 2026-2027 Summary of NACI statement of June 2026: Guidance on the use of COVID-19 vaccines starting fall 2026 Summary of updates in the Canadian Immunization Guide as of March 31, 2025: Updated guidance on quadrivalent conjugate meningococcal vaccines available in Canada